Guided Therapeutics, Inc. Reports Update on FDA Review of LuViva™ Advanced Cervical Scan PMA Application

Published: Nov 02, 2011

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced the U.S. Food and Drug Administration (FDA) has informed the company that the agency is not planning a panel review to render a decision on the Premarket Approval (PMA) application of the LuViva™ Advanced Cervical Scan.

Back to news